Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Park Ridge, IL
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Overland Park, KA
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Louisville, KY
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Boston, MA
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Omaha, NE
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Newark, NJ
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
New York, NY
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Ashville, NC
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Warwick, RI
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Dallas, TX
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Norfolk, VA
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated:  1/3/2013
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
Status: Enrolling
Updated: 1/3/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum
An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of VXA-A1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males
Status: Enrolling
Updated:  1/3/2013
Scintipharma
mi
from
Lexington, KY
Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum
An Open Label Phase I Substudy to Evaluate the Safety and Ability to Enhance Immunogenicity of VXA-A1.1 by Delivery Directly to the Ileum Using the InteliSite Companion Capsule in Healthy Adult Males
Status: Enrolling
Updated: 1/3/2013
Scintipharma
mi
from
Lexington, KY
Click here to add this to my saved trials
Pilot Text Message for Influenza Vaccination
Pilot Study of Text Message Reminders for Flu Vaccine For Adults
Status: Enrolling
Updated:  1/4/2013
Columbia University
mi
from
New York, NY
Pilot Text Message for Influenza Vaccination
Pilot Study of Text Message Reminders for Flu Vaccine For Adults
Status: Enrolling
Updated: 1/4/2013
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated:  1/8/2013
Ardmore Family Practice
mi
from
Winston-Salem, NC
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated: 1/8/2013
Ardmore Family Practice
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated:  1/8/2013
Pharmacorp Clinical Trials
mi
from
Charleston, SC
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated: 1/8/2013
Pharmacorp Clinical Trials
mi
from
Charleston, SC
Click here to add this to my saved trials
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated:  1/8/2013
Hill Country Medical Associates
mi
from
New Braunfels, TX
Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B
A Multicenter Performance Evaluation for the Ultra Influenza A&B Test Using Nasal Swabs
Status: Enrolling
Updated: 1/8/2013
Hill Country Medical Associates
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Maternal Immunization: Giving Immunity For Tomorrow
The Role of Immunizing Pregnant Women In Protecting Young Infants Against Influenza
Status: Enrolling
Updated:  1/22/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Maternal Immunization: Giving Immunity For Tomorrow
The Role of Immunizing Pregnant Women In Protecting Young Infants Against Influenza
Status: Enrolling
Updated: 1/22/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Washington Hospital Center - Obstetrics and Gynecology
mi
from
Washington,
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Washington Hospital Center - Obstetrics and Gynecology
mi
from
Washington,
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases
mi
from
Atlanta, GA
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Emory University School of Medicine - Emory Children's Center - Pediatric Infectious Diseases
mi
from
Atlanta, GA
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Emory Children's Center - Pediatric Infectious Diseases
mi
from
Atlanta, GA
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Emory Children's Center - Pediatric Infectious Diseases
mi
from
Atlanta, GA
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Saint Louis University Center for Vaccine Development
mi
from
St. Louis, MO
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Saint Louis University Center for Vaccine Development
mi
from
St. Louis, MO
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Duke Translational Medicine Institute - Clinical Vaccine Unit
mi
from
Durham, NC
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Duke Translational Medicine Institute - Clinical Vaccine Unit
mi
from
Durham, NC
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated:  1/24/2013
Group Health Research Institute - Seattle
mi
from
Seattle, WA
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women
A Randomized, Double-Blind Trial, Comparing the Safety in Mothers and Their Infants and Immunogenicity in Mothers of Live Attenuated Influenza Vaccine (LAIV) to Inactivated Trivalent Influenza Vaccine (TIV) When Administered to Breast Feeding Women
Status: Enrolling
Updated: 1/24/2013
Group Health Research Institute - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated:  1/24/2013
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated: 1/24/2013
Emory Vaccine Center - The Hope Clinic
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated:  1/24/2013
University of Iowa - Infectious Disease Clinic
mi
from
Iowa City, IA
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated: 1/24/2013
University of Iowa - Infectious Disease Clinic
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated:  1/24/2013
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated: 1/24/2013
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated:  1/24/2013
Group Health Research Institute - Seattle
mi
from
Seattle, WA
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
A Phase II Open-Label Study in Healthy Adult and Elderly Populations to Assess the Safety, Reactogenicity, and Immunogenicity of an Intramuscular Unadjuvanted Subvirion Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine
Status: Enrolling
Updated: 1/24/2013
Group Health Research Institute - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Fort Smith, AR
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Newark, DE
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Decatur, GA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Park Ridge, IL
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Bettendorf, IA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Overland Park, KA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Louisville, KY
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Metairie, LA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Boston, MA
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Rochester, MN
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
Jackson, MS
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated:  1/31/2013
Clinical Research Facility
mi
from
St. Joseph, MO
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
A Multicenter Study of the Safety of Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged Greater Than or Equal to 13 Years
Status: Enrolling
Updated: 1/31/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials